15030-72-5

Basic information

• Product Name: Z-AIB-OH
• Synonyms: Z-AIB-OH;Z-ALPHA-ME-ALA-OH;Z-ALPHA-METHYLALANINE;Z-ALPHA-AMINOISOBUTYRIC ACID;Z-2-METHYLALANINE;Z-2-AMINOISOBUTYRIC ACID;N-ALPHA-CARBOBENZOXY-ALPHA-AMINOISOBUTYRIC ACID;N-CARBOBENZYLOXY-2-METHYLALANINE
• CAS NO: 15030-72-5
• Molecular Formula: C₁₂H₁₅NO₄
• Molecular Weight: 237.25
• EINECS: 1533716-785-6
• Mol File: 15030-72-5.mol
• Article Data: 26

Chemical Properties

• Melting Point: 65-69 °C(lit.)
• Boiling Point: 379.78°C (rough estimate)
• Flash Point: 209.6 °C
• Appearance: White/Powder
• Density: 1.215
• Vapor Pressure: 6.56E-08mmHg at 25°C
• Refractive Index: 1.5200 (estimate)
• Storage Temp.: -20°C
• Solubility: soluble in Methanol
• PKA: 4.09±0.10(Predicted)
• BRN: 2218009
• CAS DataBase Reference: Z-AIB-OH(CAS DataBase Reference)
• NIST Chemistry Reference: Z-AIB-OH(15030-72-5)
• EPA Substance Registry System: Z-AIB-OH(15030-72-5)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/37/38
• Safety Statements: 24/25-26
• WGK Germany: 3
• Hazardous Substances Data: 15030-72-5(Hazardous Substances Data)

Usage

Chemical Properties

white powder

InChI:InChI=1/C12H15NO4/c1-12(2,10(14)15)13-11(16)17-8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3,(H,13,16)(H,14,15)/p-1

Upstream product

• 5938-34-1 2-amino-2-methyl-propanoic acid hydrochloride 
• 501-53-1 benzyl chloroformate 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 62-57-7 2-Aminoisobutyric acid 
• 1113-49-1 2-methylalanine ethyl ester 

Downstream Products

• 79775-03-4 2-<2-(Benzyloxycarboxamido)-2-methylpropionamido>-2-methylpropionsaeure 
• 81242-29-7 α-(Benzyloxycarbonylamino)isobutyric acid pentachlorophenyl ester 
• 84758-68-9 Z-Aib-Gly-OtBu 
• 3350-43-4 (2S)-2-[(2-[[(benzyloxy)carbonyl]amino]-2-methylpropanoyl)amino]-3-phenylpropanoic acid 
• 152972-11-7 Z-AIB-(L)-Phe-(D)-Pro-OMe 
• 91889-77-9 Z-Aib-OH 
• 15030-75-8 Z-Aib-ONp 
• 172992-10-8 methyl 2-(((benzyloxy)carbonyl)amino)-2-methylpropanoate 
• 102178-21-2 Benzyl α-<(benzyloxycarbonyl)amino>isobutanoate 
• 108874-08-4 N-carbobenzyloxy-2-methylalanylglycine 
• 101939-05-3 Z-α-Methyl-alanin-cyanmethylester 
• 30593-21-6 N-Benzyloxycarbonyl-α-amino-isobutyryl-glycin-benzylester 
• 907564-67-4 Z-Aib-Phe-OEt 
• 15030-91-8 N<α-(benzyloxycarbonylamino)isobutyryl>-L-proline methyl ester 

Relevant articles and documents

Linear Oligopeptides. Part 147. Chemical and Crystallographic Study of the Reaction between Benzyloxycarbonyl Chloride and α-Aminoisobutyric Acid

From the reaction mixture of benzyloxycarbonyl chloride and α-aminoisobutyric acid three crystalline compounds were isolated and characterized by chromatographic and spectroscopic techniques and X-ray diffraction.Two of them are polymorphic forms of the N

CHEMICAL COMPOUNDS

A compound of formula (I), wherein Ar1, R21, R23, R24, R25, R26, R27, A, X, Y and W are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne muscular dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

PYRAZOLE DERIVATIVES AS SGC STIMULATORS

There are described imidazole and pyrazole derivatives which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed.

BENZIIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS SODIUM CHANNEL MODULATORS

The invention relates to benzimidazole and imidazopyridine derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new Nav1.8 modulators of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7. X and Y are as defined in the description. Nav1.8 modulators are potentially useful in the treatment of a wide range of disorders, particularly pain.